Phase 2 Readout~quarter

Phase 2 Readout: elsunersen

Indication
SCN2A Developmental and Epileptic Encephalopathy

Other upcoming events for PRAX

PDUFA DatePDUFA Date: relutrigine
PDUFA DatePDUFA Date: relutrigine
Phase 3 ReadoutPhase 3 Topline: Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Wi
PDUFA DatePDUFA Date: relutrigine
PDUFA DatePDUFA Date: ulixacaltamide hcl

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: elsunersen — PRAX Phase 2 Readout | BioSniper